Country intelligence • Israel
Israel: market-entry intelligence
Three decisions an EU company faces with Israel. Israel is the world's #2 tech/startup ecosystem (after the US) with the highest VC per capita globally. The EU-Israel Association Agreement (since 2000) provides duty-free industrial trade. The Preferred Enterprise regime offers 7.5% CIT (Development Zone A) or 16% (elsewhere). The ILS is freely convertible. The binding constraints are the Gaza/regional conflict (Oct 7 aftermath, Iran tensions), BDS reputational risk for some EU companies, the small market (9.5M), and political instability.
How to read this page: ● measured sourced data · ◐ inferred analyst reading, basis linked · ○ projected anchored to a real starting point. Bracketed citations link to the sources at the foot of the page.
1. Trade with Israel
EU-Israel FTA
In force (EU-Israel Association Agreement)[2]
● measured The EU-Israel Association Agreement provides comprehensive duty-free access for industrial goods, making Israel one of the EU's most integrated non-member trade partners. The pharmaceutical ACAA is a distinctive feature. Bilateral science cooperation (Horizon Europe) supports R&D-intensive sectors. The agreement has survived political tensions but the EU periodically debates its scope in the context of the Israeli-Palestinian conflict. Israel's separate FTAs with the US, EFTA, and others create a well-connected trade platform.[2,3]
EU exports to Israel by sector
| SITC section | Latest month (EUR) |
|---|---|
| 7. Machinery and transport equipment | EUR 1.3bn |
| 5. Chemicals | EUR 489M |
| 8. Miscellaneous manufactured articles | EUR 333M |
| 0. Food and live animals | EUR 273M |
| 6. Manufactured goods (by material) | EUR 256M |
| 1. Beverages and tobacco | EUR 39M |
| 2. Crude materials (excl. fuels) | EUR 29M |
| 3. Mineral fuels and lubricants | EUR 19M |
| 4. Animal and vegetable oils/fats | EUR 17M |
| 9. Not classified elsewhere | EUR 13M |
Source: Eurostat COMEXT (ds-059331). [4]
The Nordic lens: Finland's position
Finland's largest export sections: Crude materials (excl. fuels) (EUR 9M), Machinery and transport equipment (EUR 5M), Manufactured goods (by material) (EUR 4M). Same COMEXT series, Finland as reporter.
Certification gate
● measured Standards Institution of Israel (SII) sets and enforces product standards. Ministry of Health regulates pharmaceuticals, food, medical devices. EU-Israel ACAA provides mutual recognition for pharmaceutical GMP. Many Israeli standards are aligned with European (EN) or international (ISO) standards.[2,5]
- SII mandatory standards for electrical products, construction materials, food contact materials, toys
- Ministry of Health pharmaceutical registration: streamlined for products approved by EU/FDA (typically 6-12 months)
- EU-Israel ACAA: mutual recognition for pharmaceutical GMP, eliminating duplicate inspections
- Kosher certification (voluntary but commercially important for domestic food market): Rabbinate supervision
- Import licensing for certain goods (agricultural products, chemicals, diamonds)
● measured The ACAA for pharmaceuticals is a significant trade facilitator. SII standards alignment with EN/ISO reduces certification barriers for European products. Kosher certification is commercially relevant for the domestic food market but not required for industrial inputs or exports.
Free Trade Agreement
● measured EU-Israel Association Agreement in force since June 2000. Provides duty-free trade for industrial goods. Agricultural trade: limited bilateral preferences (tariff-rate quotas for certain products). EU-Israel ACAA (Agreement on Conformity Assessment and Acceptance of Industrial Products) provides mutual recognition for pharmaceutical GMP, simplifying market access for pharma products.[2] Ratification status: Fully ratified and operational. The Agreement also covers political dialogue, economic cooperation, and science/technology cooperation (Horizon Europe association).
2. Establish in Israel
Entity forms
| Type | What it can do | Route / approval | Timeline |
|---|---|---|---|
| Private Company (Ltd) | Most common structure for FDI. 100% foreign ownership permitted. No restrictions. Minimum 1 shareholder, 1 director. Registration with the Companies Registrar (Rasham HaChavarot) at the Ministry of Justice. No minimum share capital requirement. | Registration: 1-2 weeks; total with bank account and tax registration: 3-6 weeks | 3-6 weeks total |
| Public Company | Listed or registered as public company. Subject to Israel Securities Authority (ISA) regulation. Dual-listed companies common (TASE + NASDAQ). Reporting requirements more extensive. Used by larger enterprises seeking public capital in Israel. | Incorporation: 2-4 weeks; ISA listing process: 3-6 months | 2-4 weeks (incorporation); listing 3-6 months |
| Branch of Foreign Company | Registration of a foreign company to operate in Israel. Not a separate legal entity. Parent has unlimited liability. Must register with the Companies Registrar and file annual returns. Suitable for project-based operations or initial market testing. | 2-4 weeks | 2-4 weeks |
| Representative Office | Permitted for marketing and liaison activities only. Cannot engage in revenue-generating activities in Israel. No separate legal entity. Minimal regulatory burden. | 1-2 weeks | 1-2 weeks |
FDI sectors: automatic vs government route
| Sector | FDI cap | Route | Note |
|---|---|---|---|
| Technology / cybersecurity | 100% | Automatic | Israel is the world's #2 tech ecosystem after the US by VC per capita (Silicon Wadi). ~6,000 active startups. Cybersecurity is a national speciality (Unit 8200 alumni pipeline). IIA provides R&D grants (20-50% of approved budget) with conditions on IP retention in Israel. Major multinationals operate R&D centres (Intel, Google, Apple, Microsoft, Amazon). |
| Pharmaceuticals | 100% | Automatic (MOH licensing for marketed products) | Teva Pharmaceutical Industries is the world's largest generic drug manufacturer. EU-Israel ACAA provides mutual recognition for pharmaceutical GMP. Israel's pharma exports are substantial (~USD 10bn+). Preferred Technology Enterprise regime (6-12% CIT) benefits IP-heavy pharma operations. |
| Defense / aerospace | Subject to security review | Conditional (Ministry of Defense approval for defense-related FDI) | Israel Aerospace Industries (IAI), Elbit Systems, Rafael Advanced Defense Systems are major players. Defense exports ~USD 13bn (2023). Foreign participation in defense is subject to security clearance and Ministry of Defense oversight. Joint ventures with Israeli companies are the typical entry route. |
| Agriculture / agtech | 100% | Automatic | Israel pioneered drip irrigation (Netafim). Agtech is a strong subsector: precision agriculture, water management, crop protection. Desert farming expertise (Negev). Limited arable land drives innovation intensity. IIA funds agtech R&D. |
| Diamonds (cutting/polishing) | 100% | Conditional (Israel Diamond Exchange membership) | Ramat Gan diamond exchange is one of the world's largest. Israel is a major diamond cutting and polishing centre. The sector has declined in relative importance (from ~25% of exports in 2000s to <10% now) but remains significant. Subject to Kimberley Process compliance. |
| Renewable energy (solar) | 100% | Automatic (IEC/PUA licensing for generation) | Negev desert solar potential. Israel targets 30% renewable electricity by 2030. Solar capacity growing rapidly. Public Utility Authority (PUA) regulates electricity generation. Net-metering and feed-in tariffs available. Water desalination (5 major plants) is energy-intensive, creating demand. |
| Financial services | 100% | Conditional (Bank of Israel / ISA licensing) | Banking sector concentrated (5 major banks: Leumi, Hapoalim, Discount, Mizrahi-Tefahot, FIBI). Bank of Israel regulates. Fintech growing rapidly. ISA regulates securities. Insurance regulated by Capital Markets, Insurance and Savings Authority. |
Corporate tax rates
| Scenario | Basic rate | Effective rate | Note |
|---|---|---|---|
| Standard | 23% | 23% | Applies to all resident companies on worldwide income. Non-residents taxed on Israel-source income. |
| Preferred Enterprise (Development Zone A) | 7.5% | 7.5% | Applies to qualifying industrial enterprises in Development Zone A (Negev, Galilee). Must meet export thresholds or contribute to tech development. |
| Preferred Enterprise (elsewhere) | 16% | 16% | Qualifying industrial enterprises outside Development Zone A. Must meet revenue and export thresholds. |
| Preferred Technology Enterprise | 6-12% | 6-12% | 6% in Development Zone A, 12% elsewhere. For companies with qualifying IP income. Minimum R&D expenditure and employee thresholds apply. |
| Special Preferred Technology Enterprise | 6% | 6% | For very large technology companies (revenue >NIS 10bn). Requires Minister of Finance approval. |
MAT: No minimum alternative tax.. Foreign company PE rate: 23% on Israel-source income. Reduced rates under Preferred Enterprise regime for qualifying operations..[1]
Value-added tax (VAT / Ma'am)
18%[1]
VAT at 18% standard rate (increased from 17% in Jan 2025). Exempt: financial services, rental income (residential), certain exports. Zero-rated: exports of goods and services. Eilat free trade zone: VAT-exempt.
Withholding tax / TDS (key rates for EU parent)
| Type | Rate | Note |
|---|---|---|
| Dividends to non-resident | 25-30% | 25% standard; 30% for substantial shareholders (10%+ holding). Reducible to 5-15% under DTAs. Israel has 55+ DTAs. |
| Interest to non-resident | 23-25% | 23% for companies, 25% for individuals. Reducible under DTAs. |
| Royalties to non-resident | 23-25% | 23% for companies, 25% for individuals. Reducible under DTAs. |
| Service fees to non-resident | 23-25% | Technical and management service fees. May be reduced under DTAs. |
Payment and currency
● measured Floating exchange rate. The Israeli shekel (ILS) is fully convertible with no capital controls. Bank of Israel manages monetary policy with an inflation-targeting framework. ILS/EUR ~3.7 (mid-2026). The shekel has been relatively stable in recent years, strengthened by tech-sector FX inflows. Post-Oct 7 (2023): temporary depreciation (~12%) followed by recovery as Bank of Israel deployed USD 45bn in reserves.[8,5] Fully free. No restrictions on profit repatriation, capital transfers, or dividend payments. Israel has no capital controls. OECD member with full capital account openness.
◐ inferred Payment terms in Israeli B2B trade are typically 30-60 days (EOM+30 is common). Cheque usage has declined but remains more common than in EU markets. Electronic payments and credit cards are standard. Banking sector is well-developed and stable. Trade finance instruments (LCs, guarantees) available from all major banks. Israel's financial system is sophisticated and integrated with global markets.[5]
Production-Linked Incentives
● measured Israel's investment incentive framework centres on the Encouragement of Capital Investments Law, which provides reduced CIT rates for Preferred Enterprises and Technology Enterprises. The Israel Innovation Authority (IIA) provides R&D grants (20-50% of approved budget) with conditions on IP retention in Israel. Binational R&D funds (BIRD with US, CIIRDF with Canada, KORIL with South Korea) fund joint ventures.[6,5,1]
| Sector | Status |
|---|---|
| Technology / cybersecurity | World's #2 tech ecosystem by VC per capita. ~6,000 active startups. IIA provides R&D grants. Unit 8200 alumni pipeline feeds cybersecurity sector. Beer-Sheva CyberSpark is a dedicated cyber innovation hub. Preferred Technology Enterprise regime (6-12% CIT) benefits qualifying tech companies. |
| Pharmaceuticals | Teva (world's largest generic manufacturer), Perrigo, Protalix. EU-Israel ACAA for pharmaceutical GMP. Preferred Technology Enterprise regime benefits IP-heavy pharma. Strong clinical trial infrastructure (diverse population, universal health records). |
| Defense / aerospace | IAI, Elbit Systems, Rafael. Defense exports ~USD 13bn (2023). Government is both customer and co-investor. Defense R&D benefits from military service culture and IMOD (Ministry of Defense) funding. |
| Agriculture / agtech | Netafim (drip irrigation), Rivulis, Phytec. Desert agriculture expertise. IIA funds agtech R&D. Water technology is a national speciality (desalination, recycled wastewater for irrigation ~90% reuse rate, world-leading). |
| Renewable energy | 30% renewable electricity target by 2030. Negev solar development. EDF Renewables, Energix, Doral operating. PUA feed-in tariffs. Growing battery storage and green hydrogen interest. |
| Diamonds | Ramat Gan diamond exchange. Declining share of exports but still significant. Cutting and polishing expertise. Kimberley Process compliance. Lab-grown diamonds emerging. |
IIA R&D grants come with conditions: IP developed with IIA funding must generally remain in Israel (transfer requires approval and repayment). This can constrain exit strategies for startups and acquisitions. The Preferred Enterprise regime requires ongoing compliance with employment and revenue thresholds. The high cost of living and doing business in Israel (rent, labour) offsets some tax advantages.
Labour framework
● measured Israel's employment law is a mix of legislation and collective agreements. Minimum wage: NIS ~5,880/month (~EUR 1,500). Employer social contributions: National Insurance Institute (Bituach Leumi) ~7.6% + pension ~6.5% + severance fund ~8.33%. Standard working week: 42 hours (reduced from 43 in 2018). Overtime: 125% for first 2 hours, 150% thereafter. Annual leave: 12-28 days depending on tenure. Labour law is national (no state-level variation). Labour courts handle disputes. Strong labour unions in traditional sectors (Histadrut) but minimal in tech sector. The tech sector operates largely outside collective agreements with market-driven compensation.[5]
- Minimum wage NIS ~5,880/month (2025); adjusted periodically
- Employer social contributions: NII ~7.6%, pension ~6.5%, severance ~8.33% of salary; total employer burden ~22%+
- Severance pay: 1 month salary per year of service (Section 14 arrangement allows conversion to pension fund contributions)
- Work permits for foreigners: B/1 work visa via Population and Immigration Authority; tech sector has streamlined expert visa tracks
- High-tech sector: acute talent competition; average tech salary ~NIS 28,000/month; significant salary inflation post-COVID
The opportunity
Israel's opportunity for EU companies rests on its position as the world's #2 tech ecosystem, the Preferred Enterprise tax regime (7.5% CIT in Development Zone A), duty-free industrial trade under the EU Association Agreement, IIA R&D grants, and ACAA pharma mutual recognition.
EU Association
Duty-free[]
Industrial goods since 2000
Tech/cyber #2 globally
● measured Israel is the world's second-largest tech/startup ecosystem after the US, with the highest VC investment per capita globally. Cybersecurity is a standout vertical. EU companies access talent, co-development, and acquisition targets.[5]
Preferred Enterprise 7.5%
● measured The Preferred Enterprise regime offers 7.5% CIT for companies in Development Zone A and 16% elsewhere. This makes Israel competitive on effective tax rate for tech and manufacturing operations.[1]
EU Association duty-free
● measured The EU-Israel Association Agreement (in force since 2000) provides duty-free access for industrial goods. Agricultural products have preferential but not fully liberalized access.[]
ACAA pharma mutual recognition
● measured The Agreement on Conformity Assessment and Acceptance of Industrial Products (ACAA) covers pharmaceutical GMP, enabling mutual recognition between EU and Israeli regulators.[5]
3. Dangers register
5 entries across 5 categories. Each states the mechanism (how it bites an EU company), the evidence (sourced), the mitigation, and what evidence would change the assessment.
Gaza war, Iran tensions, and regional escalation risk
The Oct 7 2023 Hamas attack and subsequent Gaza war have fundamentally altered Israel's security environment. Iran launched direct missile and drone strikes on Israel (April 2024, October 2024). Hezbollah conducted a sustained rocket campaign from Lebanon (October 2023 to November 2024 ceasefire). Houthi attacks on Red Sea shipping disrupted Eilat port trade. The conflict has caused economic disruption: ~300,000 reservists mobilised (reducing civilian workforce by ~8%), northern border communities evacuated, tourism collapsed, construction slowed (dependence on Palestinian and foreign workers).
● measured GDP growth: 2% (2023) vs 6.5% (2022). Reservist mobilisation: ~8% of workforce. Eilat port traffic down ~50% due to Houthi attacks. Northern Israel: ~60,000 evacuated from border communities. Tourism arrivals down ~75% (2024 vs 2023). Bank of Israel deployed USD 45bn in reserves to stabilise ILS. Credit rating: Moody's downgraded from A1 to A2 (Feb 2024); S&P and Fitch placed on negative outlook.[9,13]
BDS movement and reputational risk for EU companies
The BDS (Boycott, Divestment, Sanctions) movement campaigns for economic pressure on Israel over the Palestinian issue. Some EU institutional investors, pension funds, and consumer brands face pressure to divest from or restrict operations linked to Israel, particularly the occupied territories. Norway's Government Pension Fund Global (GPFG) has excluded some Israeli companies. The EU differentiates between Israel proper and settlements (EU guidelines prohibit funding to settlement-based entities). For some EU companies, operating in Israel creates reputational exposure with certain customer segments and ESG screening frameworks.
◐ inferred Norway GPFG: excluded Elbit Systems, Bezeq, and others. Some EU pension funds restrict settlement-linked investments. EU labelling regulation requires distinction between Israel and settlements. Ireland's Occupied Territories Bill (passed 2023) restricts trade with settlements. Ben & Jerry's (Unilever) settlement withdrawal controversy (2021-2022). Post-Oct 7: BDS pressure has intensified in some EU markets.[10]
Coalition instability and judicial reform crisis
Israel's proportional representation system (120-seat Knesset, 3.25% threshold) produces fragmented coalitions. The country held 5 elections in less than 4 years (2019-2022). The judicial reform crisis of 2023 (government attempt to limit Supreme Court override power) triggered mass protests, threats by reserve officers to refuse service, and international investor concern. Credit rating agencies placed Israel on watch. The combination of coalition fragility and deep societal polarisation (secular/religious, left/right, Jewish/Arab) creates policy unpredictability.
● measured Elections: Apr 2019, Sep 2019, Mar 2020, Mar 2021, Nov 2022. Judicial reform protests: 39 consecutive weeks of mass demonstrations (2023). Tech-sector leaders threatened capital flight. Moody's cited governance concerns in downgrade rationale. Reserve pilot and special forces refusal letters (subsequently walked back after Oct 7).[12]
Gaza war, Iran tensions, and regional escalation risk
Mechanism: The Oct 7 2023 Hamas attack and subsequent Gaza war have fundamentally altered Israel's security environment. Iran launched direct missile and drone strikes on Israel (April 2024, October 2024). Hezbollah conducted a sustained rocket campaign from Lebanon (October 2023 to November 2024 ceasefire). Houthi attacks on Red Sea shipping disrupted Eilat port trade. The conflict has caused economic disruption: ~300,000 reservists mobilised (reducing civilian workforce by ~8%), northern border communities evacuated, tourism collapsed, construction slowed (dependence on Palestinian and foreign workers).
Evidence: GDP growth: 2% (2023) vs 6.5% (2022). Reservist mobilisation: ~8% of workforce. Eilat port traffic down ~50% due to Houthi attacks. Northern Israel: ~60,000 evacuated from border communities. Tourism arrivals down ~75% (2024 vs 2023). Bank of Israel deployed USD 45bn in reserves to stabilise ILS. Credit rating: Moody's downgraded from A1 to A2 (Feb 2024); S&P and Fitch placed on negative outlook.[9,13]
Current status: Active. The Gaza war continues with uncertain endgame. Iran-Israel confrontation has established a new direct-strike precedent. Lebanon ceasefire (Nov 2024) is fragile. The risk of wider regional escalation (Iran nuclear programme, Strait of Hormuz) persists. Red Sea/Houthi situation unresolved.
Mitigation: Assess business continuity under escalation scenarios. Ensure contracts include force majeure provisions calibrated to the region. Consider dual supply chain routing (avoid sole dependence on Eilat/Red Sea). For tech-sector investments: Israel's tech ecosystem has shown resilience, but talent availability during reservist call-ups is a real constraint. Insurance: war-risk premiums have increased significantly.
What would change the assessment: Durable ceasefire and political settlement in Gaza. Iran nuclear deal revival or credible deterrence equilibrium. Stable Lebanon border arrangement. Resolution of Houthi Red Sea campaign.
BDS movement and reputational risk for EU companies
Mechanism: The BDS (Boycott, Divestment, Sanctions) movement campaigns for economic pressure on Israel over the Palestinian issue. Some EU institutional investors, pension funds, and consumer brands face pressure to divest from or restrict operations linked to Israel, particularly the occupied territories. Norway's Government Pension Fund Global (GPFG) has excluded some Israeli companies. The EU differentiates between Israel proper and settlements (EU guidelines prohibit funding to settlement-based entities). For some EU companies, operating in Israel creates reputational exposure with certain customer segments and ESG screening frameworks.
Evidence: Norway GPFG: excluded Elbit Systems, Bezeq, and others. Some EU pension funds restrict settlement-linked investments. EU labelling regulation requires distinction between Israel and settlements. Ireland's Occupied Territories Bill (passed 2023) restricts trade with settlements. Ben & Jerry's (Unilever) settlement withdrawal controversy (2021-2022). Post-Oct 7: BDS pressure has intensified in some EU markets.[10]
Current status: Active and intensifying post-Oct 7. The reputational risk is sector-dependent: consumer brands face higher exposure than B2B tech companies. The EU's legal distinction between Israel and settlements is the key regulatory line. US states' anti-BDS legislation creates counter-pressure.
Mitigation: Assess supply chain and operational footprint relative to the Green Line (1967 border). Ensure no operations in settlements unless the business case warrants the reputational exposure. For consumer brands: conduct market-specific reputational risk assessment. For B2B/tech: exposure is typically lower but ESG screening is expanding.
What would change the assessment: Israeli-Palestinian political settlement. Reversal of settlement expansion. EU-wide legal clarity on business engagement with settlements. ESG framework standardisation on the question.
Small market (9.5M population) with high cost of doing business
Mechanism: Israel's population is ~9.5M, comparable to Austria or Sweden. The domestic market is inherently limited. The cost of living and doing business is among the highest in the OECD: housing costs in Tel Aviv and central Israel are extreme (price-to-income ratio among OECD's worst), food prices are ~20% above EU average, and tech-sector salaries have inflated significantly (average tech salary ~NIS 28,000/month, ~EUR 7,000). Labour costs, rent, and regulatory compliance make Israel expensive for operations that serve only the local market.
Evidence: Population: ~9.5M. Tel Aviv: ranked #5 globally in Economist's cost of living index (2023). Housing: median apartment price in Tel Aviv ~NIS 3.5M (~EUR 870K). Average tech salary ~NIS 28,000/month. Food CPI ~20% above EU average. OECD ranks Israel's housing affordability among worst in membership.[11,5]
Current status: Structural. The cost problem is persistent and unlikely to change. Successful foreign investors treat Israel as an R&D/innovation hub (leveraging talent and incentives) with products sold globally, not as a primary market for domestic sales.
Mitigation: Structure Israel operations as R&D/innovation centres serving global markets, not as primary revenue centres for the domestic market. Leverage Preferred Enterprise and Technology Enterprise tax incentives (7.5-12% CIT) to offset high operating costs. Consider Beersheba/Haifa (lower costs than Tel Aviv) for R&D centres.
What would change the assessment: Structural: population growth (1.5% annual, among OECD's fastest) gradually expands the domestic market. Housing reform. Tech-salary normalisation if global tech downturn persists.
Coalition instability and judicial reform crisis
Mechanism: Israel's proportional representation system (120-seat Knesset, 3.25% threshold) produces fragmented coalitions. The country held 5 elections in less than 4 years (2019-2022). The judicial reform crisis of 2023 (government attempt to limit Supreme Court override power) triggered mass protests, threats by reserve officers to refuse service, and international investor concern. Credit rating agencies placed Israel on watch. The combination of coalition fragility and deep societal polarisation (secular/religious, left/right, Jewish/Arab) creates policy unpredictability.
Evidence: Elections: Apr 2019, Sep 2019, Mar 2020, Mar 2021, Nov 2022. Judicial reform protests: 39 consecutive weeks of mass demonstrations (2023). Tech-sector leaders threatened capital flight. Moody's cited governance concerns in downgrade rationale. Reserve pilot and special forces refusal letters (subsequently walked back after Oct 7).[12]
Current status: Manageable but structural. Oct 7 created a temporary national unity dynamic but underlying polarisation persists. Post-war political reckoning (commission of inquiry, elections) will reopen divisions. For investors, the risk is not regime change but policy instability: regulatory changes, tax amendments, and institutional modifications can occur with each coalition shift.
Mitigation: Ensure contractual protections against regulatory change. Monitor coalition dynamics and Knesset committee activities. Israel's independent institutions (Bank of Israel, courts, civil service) provide continuity between governments. For long-term investments, structural factors (tech ecosystem, human capital, infrastructure) are more durable than coalition politics.
What would change the assessment: Electoral reform (raising threshold, introducing constructive no-confidence vote). Post-war national consensus on judicial reform. Stable governing coalition lasting a full 4-year term.
Credit rating deterioration and war-related fiscal pressure
Mechanism: The Gaza war has imposed significant fiscal costs on Israel: military spending surged (~4.5% of GDP in 2024 vs ~5% pre-war baseline including Iron Dome/Arrow), reconstruction of damaged communities, reservist compensation, and social spending for displaced populations. Moody's downgraded Israel from A1 to A2 (February 2024), citing governance and fiscal concerns. S&P and Fitch placed their ratings on negative outlook. The debt-to-GDP ratio has risen (from ~60% to ~67% in 2024). Further downgrades would increase government borrowing costs and signal deeper institutional concerns.
Evidence: Moody's: A1 to A2 (Feb 2024), further downgrade to Baa1 (Sep 2024). S&P: AA- with negative outlook. Fitch: A+ with negative outlook. Defense spending: ~4.5% of GDP (2024). Debt-to-GDP: ~67% (2024) vs ~60% (2022). Budget deficit: ~8% of GDP (2024) vs 1% (2022).[13,9]
Current status: Active. Fiscal consolidation depends on war duration and post-war reconstruction costs. Israel's underlying fiscal capacity is strong (tech-driven tax base, effective tax collection) but the war is straining public finances. Further credit downgrades are possible if the war continues or escalates.
Mitigation: Monitor credit rating actions and fiscal data closely. Israel's shekel bond market remains deep and liquid. For corporate borrowers in Israel, benchmark against sovereign spread. The credit deterioration is war-driven, not structural: if/when the security situation stabilises, ratings recovery is likely.
What would change the assessment: War conclusion and fiscal consolidation. Defense spending returning to pre-war baseline. Debt-to-GDP stabilising below 70%. Rating agency upgrades or outlook revision to stable.
13 primary sources spanning EU/Israeli government publications, WTO tariff data, Eurostat trade data, and specialist legal/tax summaries.
- [1] PwC / ICLG, Israel Corporate Tax Laws (2026): 23% standard CIT, Preferred Enterprise 7.5% (Development Zone A) or 16%, Preferred Technology Enterprise 6-12%
- [2] EU-Israel Association Agreement: in force since Jun 2000; duty-free industrial trade; limited agricultural preferences; EU-Israel ACAA for pharmaceutical GMP mutual recognition
- [3] WTO, World Tariff Profiles 2025: Israel
- [4] Eurostat COMEXT (ds-059331): EU27 and Finland trade with Israel by SITC section, monthly
- [5] US Department of State / Chambers, 2025-2026 Investment Climate: Israel
- [6] Israel Innovation Authority (IIA): R&D grants (20-50% of approved budget), incubator programmes, binational funds (BIRD with US, CIIRDF with Canada); conditions on IP retention in Israel
- [7] Transparency International, CPI 2025: Israel score ~62/100, rank ~30/182
- [8] Bank of Israel: ILS/EUR ~3.7 (mid-2026); floating exchange rate; no capital controls; inflation targeting framework
- [9] ICG / IISS: Oct 7 2023 Hamas attack, Gaza war (2023-), Iran missile/drone strikes (Apr 2024, Oct 2024), Hezbollah rocket campaign (Oct 2023 - Nov 2024 ceasefire), Houthi attacks on Red Sea shipping affecting Eilat port
- [10] BDS (Boycott, Divestment, Sanctions) movement: some EU institutional investors, pension funds, and consumer brands face pressure to divest or restrict Israel-linked operations; Norway GPFG excluded some Israeli companies; legal restrictions on BDS in some US states and Germany
- [11] OECD / Numbeo: Israel ranks among the most expensive OECD countries for housing, food, and childcare; Tel Aviv consistently in global top 10 most expensive cities; housing crisis is a persistent political issue
- [12] Israel held 5 elections in 4 years (2019-2022); judicial reform crisis (2023) triggered mass protests, reserve officer refusal threats, credit rating watch; coalition instability is structural in the proportional representation system
- [13] Bank of Israel: deployed ~USD 45bn in reserves post-Oct 7 to stabilise ILS; reserves recovered to ~USD 215bn (mid-2025); credit rating agencies placed Israel on negative outlook (Moody's downgraded to A2, S&P and Fitch on negative watch)
As of August 2026. Statutory facts verified against primary sources; practice claims cite the basis.